On Thursday, Following Stocks were among the “Top Gainers” In U.S. Stock Exchange: Melco Crown Entertainment Ltd (ADR) (NASDAQ:MPEL), Sinclair Broadcast Group Inc (NASDAQ:SBGI), Ariad Pharmaceuticals, Inc (NASDAQ:ARIA), Pacific Sunwear of California, Inc (NASDAQ:PSUN)
Melco Crown Entertainment Ltd (ADR) (NASDAQ:MPEL)’s shares picked up 4.59%, and closed at $22.88. The stock has the beta value of 2.21, and its volatility for the week is 3.60%, while for the month it is 3.65%. The company has the market capitalization of $11.76B. The company holds the book value per share of 7.86, whereas cash per share is 3.14. Price to book ratio remained 2.59, while price to sale ratio is 2.91. Analysts mean recommendation for the stock is said to be 2.30 (where 1=Buy, 5=sale).
Melco Crown Entertainment Limited, through its subsidiaries, develops, owns, and operates casino gaming and entertainment resort facilities in Asia. It owns and operates City of Dreams, an integrated casino resort that has 480 gaming tables and 1,400 gaming machines; about 1,400 hotel rooms and suites; a wet stage performance theater with about 2,000 seats; about 20 restaurants and bars, and 70 retail outlets; and recreation and leisure facilities, counting health and fitness clubs, swimming pools, spa and salons, and banquet and meeting facilities. The company also operates Altira Macau, a casino hotel, which has about 140 gaming tables; 230 hotel rooms; and various non-gaming entertainment venues comprising spa, gymnasium, outdoor garden podium, and sky terrace lounge.
Sinclair Broadcast Group Inc (NASDAQ:SBGI), raised 4.43%, and closed at $30.40. The company holds the market capitalization of $2.77B. For the last twelve months, the stock was able to keep return on equity at 56.70%, while return on assets at 4.50%, in response to its return on investment at 8.60%. Its 20-day moving average gained 9.66%, above 50-day moving average of 15.24%, above 200-day moving average of 7.69% from the latest market price of $30.40. The mean recommendation of analysts for this stock is 1.90.(where 1=Buy, 5=Sale).
Sinclair Broadcast Group, Inc., a diversified television broadcasting company, owns and operates, programs, or provides sales services to television stations in the United States. It broadcasts free over-the-air programming, such as network provided programs, news produced locally, local sporting events, programming from program service arrangements, syndicated entertainment programs, and other locally produced programs. The company owns and provides programming and operating services following local marketing agreements, or provides sales services following outsourcing agreements to 164 stations in 79 markets, which broadcast 373 channels. It also offers sign design and fabrication services; and security alarm monitoring and bulk attainment services. In addition, the company invests in various real estate ventures, counting developmental land, and operating commercial and multi-family residential real estate properties and apartments, in addition to in private equity and structured debt/mezzanine financing investment funds. Further, it manufactures and services television broadcast antennas and transmitters. The company was founded in 1986 and is headquartered in Hunt Valley, Maryland.
Ariad Pharmaceuticals, Inc (NASDAQ:ARIA), enhanced 4.42%, and closed at $8.97, hitting new 52-week high of $9.09. The company has the market capitalization of $1.61B. The beta value of the stock is 1.51. On the other hand the stock’s volatility for the week is 3.76%, and for the month is 4.71%. The stock’s price to book ratio is 20.86, however price to sale ratio is 15.96. Analyst’s mean recommendation regarding this stock is 2.60. (where 1=Buy, 5=Sale).
ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult patients with chronic myeloid leukemia (CML), and Philadelphia chromosome-positive acute lymphoblastic leukemia in the United States, Europe, and other territories. It also develops Brigatinib, an investigational inhibitor of anaplastic lymphoma kinase for the treatment of various patients with a form of non-small cell lung cancer; and AP32788, an orally active TKI for treating non-small cell lung cancer and various other solid tumors. The company sells and markets Iclusig through specialty pharmacies and specialty distributors in the United States. It has license agreements with Medinol Ltd. and ICON Medical Corp. to develop and commercialize stents and other medical devices to deliver ridaforolimus. ARIAD Pharmaceuticals, Inc. was founded in 1991 and is headquartered in Cambridge, Massachusetts.
Pacific Sunwear of California, Inc (NASDAQ:PSUN), rose 4.41%, and closed at $2.84. The stock volatility for the week is 6.37%, while for the month remained 4.47%. The company holds consensus target price of $3.22.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed -0.36diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 11.50% and Annual EPS growth for the past 5 years is considered as -3.20%.
The mean recommendation of analysts for this stock is 2.30. (where 1=Buy, 5=Sale).
Pacific Sunwear of California, Inc., together with its subsidiaries, operates as a specialty retailer in the action sports, fashion, and music influences of the California lifestyle. It sells a combination of branded and proprietary casual apparel, accessories, and footwear designed for teens and young adults. The company primarily operates mall-based chain of retail stores under the brand names of Pacific Sunwear and PacSun; and an e-commerce Website at pacsun.com, which sells PacSun merchandise online, and provides content and community for its target customers. As of May 29, 2014, it operated 619 stores in 50 states and Puerto Rico. The company was founded in 1982 and is headquartered in Anaheim, California.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
